Trade Agreement: Canadian Free Trade Agreement (CFTA) Tendering Procedures: Generally only one firm has been invited to bid Non-Competitive Procurement Strategy: Exclusive Rights Comprehensive Land Claim Agreement: No Vendor Name and Address:
VARIOUS PHARMACEUTICALS SUPPLIERS VARIOUS VARIOUS Ontario Canada A1A1A1 Nature of Requirements:
1. Definition of the requirement
PWGSC proposes to establish contract pricing with manufacturers of patent protected pharmaceuticals on behalf of the Federal/Provincial/Territorial (F/P/T) Group Purchasing Program for Drugs and Vaccines on an as-and-when requested basis.
2. Criteria for assessment of the Statement of Capabilities (Minimum Essential Requirements)
Any interested supplier must demonstrate by way of a statement of capabilities that its pharmaceutical product meets the following requirements:
a) Must have a valid DIN number; b) Must have the same active pharmaceutical ingredient (API) and strength as indicated in the list below. c) Must be able to deliver on a national scale.
3. Applicability of the trade agreement(s) to the procurement
This procurement is subject to the Canadian Free Trade Agreement (CFTA)
4. Justification for the Pre-Identified Supplier
This requirement is being negotiated with the following suppliers as they are the only known suppliers capable of providing the drugs listed at the bottom of this document.
The suppliers are:
AA Pharma, AbbVie, Amgen, ASM Canada, Astra Zeneca, Bausch Health Canada Inc., Bayer, BGP Pharma, Biogen Idec Canada, Boehringer Ingelheim, Bristol-Myers Squibb, Church & Dwight, Eli Lilly, Galderma Canada, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen, Johnson & Johnson, Leo Pharma, Lundbeck, Mallinckrodt Canada, Merck, Novartis, Novo Nordisk, Omega Laboratories, Otsuka Canada Pharma, Pfizer Canada, Pharmascience, Purdue Pharma, Sanofi-Aventis, Shire Canada, Smith & Nephew, Sterimax, Sunovion Pharma, Takeda, Taro Pharmaceuticals, Teligent, Teva, Valeant, and Viiv Healthcare.
5. Government Contracts Regulations Exception(s) The following exception(s) to the Government Contracts Regulations is invoked for this procurement under subsection 6(d) as only one supplier is capable of performing the work.
6. Period of the proposed contract or delivery date
From July 1, 2019 to June 30, 2020, with an option to extend the contract period for two additional one-year periods from July 1, 2020 to June 30, 2021 and July 1, 2021 to June 30, 2022.
7. Closing date for a submission of a statement of capabilities
The closing date and time for accepting statements of capabilities is May 31, 2019 at 2:00 p.m.
8. Inquiries and statements of capabilities are to be directed to:
Julia Summers Telephone: (613) 859-0832 E-mail:
julia.summers@tpsgc-pwgsc.gc.ca
LIST OF ITEMS
AVENTYL CAPS 10MG
100 AVENTYL CAPS 25MG
100 PEN VK TB 300MG
100 LUPRON DEPOT INJ KIT 11.25MG LUPRON DEPOT INJ KIT 22.5MG1 LUPRON DEPOT INJ KIT
3.75MG LUPRON DEPOT INJ KIT 30MG
1 LUPRON DEPOT INJ KIT 7.5MG 1 HUMIRA PN 40MG/0.8ML 2X0.8ML KALETRA TB 200-50MG
120 NORVIR TB 100MG
30 ARANESP SYR 500MCG
1ML ARANESP SYR 40MCG
4X0.4ML ARANESP SYR 60MCG
4X0.3ML ARANESP SYR 80MCG
4X0.4ML ENBREL 50MG/ML SURECLICK
4 NEUPOGEN VL 300MCG
10X1ML PULMICORT NEB 0.25MG
20X2ML PULMICORT NEB 0.5MG
20X2ML RHINOCORT TUBUHALER INH 100MCG 200DS PULMICORT TURBUHALER INH 200MCG 200DS SYMBICORT TURBUHALER INH 100MCG 120DS SYMBICORT TURBUHALER INH 200MCG
60DS BRILINTA TB 90MG UD
4X15 NIX CR RIN LICE 1%
59ML KWELLADA-P 5% PERM LOT 100ML ZYCLARA CR 3.75% PUMP
7.5G ALDARA P CREAM 5% PUMP
7.5G MIRENA IUS
1 YAZMIN TB
28 YASMIN TB
21 AERIUS ALRGY DESLO TB 5MG 100 XARELTO TB 10MG
50 XARELTO TB 15MG
90 XARELTO TB 20MG
90 KADIAN CAPS 10MG
100 KADIAN CAPS 100MG
50 KADIAN CAPS
20MG
100 KADIAN CAPS
50MG
100 SYNTHROID TB 0.1MG
1000 SYNTHROID TB 112MCG
90 SYNTHROID TB 0.125MG
1000 SYNTHROID TB 137MCG
90 SYNTHROID TB 0.15MG
1000 SYNTHROID TB 0.175MG
1000 SYNTHROID TB 200MCG
90 SYNTHROID TB 0.025MG
1000 SYNTHROID TB 0.05MG
1000 SYNTHROID TB 0.075MG
1000 SYNTHROID TB 88MCG
90 TECFIDERA CAPS 240MG
56 AVONEX PEN PRE-FIL 30MCG 1X4 ATROVENT INHALER HFA
200DS JARDIANCE TB 10MG BLST
90 JARDIANCE TB 25MG BLST
30 TRAJENTA TB 5MG UD BLS
9X10 ELIQUIS TB 2.5MG
60 ELIQUIS TB 5MG
BLS 6X10 SPRYCEL TB 80MG
30 ATASOL 15 COD TB 100 ATASOL 30 COD TB 100 GLUCAGON RDNA SYR 1MG
1X1ML INS HUMALOG CARTRIDGE
5X3ML INS HUMULIN R CART
5X3ML DEPO TESTOST 100MG/ML
10ML INS HUMULIN N CART
5X3ML DIPHENHYDRAM INJ 50MG 25X1ML METROCREAM CR 0.75%
60G METROGEL TOP GEL 0.75% 60G METROGEL TOP GEL 1%
55G GENVOYA 150/150/200/10MG
30 STRIBILD 150/150/200/300MG30 ODEFSEY TB
200/25/25MG 30 COMPLERA TB 300MG
30 DESCOVY TB 200/10MG
30 DESCOVY TB 200/25MG
30 VOSEVI TB 400/100/100MG
28 FLOVENT HFA 125MCG/DS
120DS FLOVENT HFA 250MCG/DS
120DS ADVAIR MDI INH 125MCG
120DS ADVAIR MDI INH 250MCG
120DS NIX DERM CR 5%
30G FLOVENT DISK PD 250MCG
60DS ADVAIR DISKUS 50/250MCG INHALER
60DS ADVAIR DISKUS 50/500MCG INHALER
60DS FUZEON KIT VL 108MG
1 RITUXAN VL
10MG/ML 1X50ML SPORANOX CAPS 100MG
30 REMICADE VL
10MG/ML
100MG RISPERDAL CONSTA KIT
25MG RISPERDAL CONSTA KIT
37.5MG RISPERDAL CONSTA KIT
50MG EPREX SYR 1000IU
6X0.5ML EPREX SYR 2000IU
6X0.5ML EPREX SYR 3000IU
6X0.3ML EPREX SYR 4000IU
6X0.4ML EPREX SYR 5000IU
6X0.5ML EPREX SYR 6000IU
6X0.6ML EPREX SYR 8000IU
6X0.8ML EPREX SYR 10000IU
6X1ML EPREX SYR 40000IU
1X1ML SIMPONI SYR 50MG
0.5ML SIMPONI A/INJECT 100MG
1ML SIMPONI A/INJECT 50MG
0.5ML INVEGA SUSTENNA SYR 150MGPFS INVEGA SUSTENNA SYR 50MG PFS INVEGA TRINZA SYRN 175MG
1 INVOKANA TB 100MG UD
30 INVOKANA TB 300MG UD
30 PREZISTA TB 150MG
240 PREZISTA TB 600MG
60 PREZISTA TB 800MG
30 CYCLEN DISCREET TB
28 TRI-CYCLEN DISCREET TB
28 INVEGA TB XR
3MG
30 INVEGA TB XR
6MG
30 DOVOBET GEL 50MCG/0.5MG
60G DOVONEX OINT 50MCG/G
30G DOVOBET OINTMENT
120G PROTOPIC OINT 0.03%
30G PROTOPIC OINT 0.10%
30G FLUANXOL DEPOT100MG/ML
10X1ML CLOPIXOL DEP 200MG/ML 10X1ML TRINTELLIX TB 10MG
28 TRINTELLIX TB 20MG
28 TRINTELLIX TB 5MG
28 METHADOSE CHY ORAL SOL
1L METHADOSE N/DYE S/F UNFLV 1L ASMANEX TWISTHALER 200MCG 60 ASMANEX TWISTHALER 400MCG 60 NUVARING VAG RING
3 ISENTRESS TB 400MG
60 JANUMET TB 50MG/1000MG
60 JANUMET TB 50MG/500MG
60 JANUMET XR TB 50MG/1000MG 60 JANUVIA TB 100MG
100 JANUVIA TB 50MG
30 GILENYA CAPS
0.5MG
2X14 SEEBRI BREEZHALER 50MCG 3X10 LAMISIL CR 1%
30G LAMISIL SP 1%
30ML CIPRODEX OTIC SUSP
7.5ML EXJADE TB 500MG BLST
28 INSUL NOVORAPID PEN
5X3ML VICTOZA PRE FILLED
3X3.0ML SAXENDA 6MG/ML PNPREFIL5X3ML INSUL NOV GE NPH PEN
5X3ML ABILIFY MAINTENA VL
300MG ABILIFY MAINTENA VL
400MG FRAGMIN SYRN 10000IU 5X0.4ML FRAGMIN SYRN 12500IU 5X0.5ML FRAGMIN SYRN 15000IU 5X0.6ML FRAGMIN SYRN18000IU 5X0.72ML FRAGMIN SYRN 5000IU 10X0.2ML FRAGMIN SYRN 7500IU
5X0.3ML FRAGMIN VL
25000IU/ML 3.8ML DEXTROSE ANS 50% 25G/50ML 10X50ML DEXTROSE SYR 50% LIFESHIELD
50ML DEXTROSE SYR 50% 25G/50ML
10X50ML INS HUMALOG KW 100U/ML 5X3ML DEPO PROVERA 150MG/ML
1ML ROBAXIN TB 500MG
50 IBAVYR TB 400MG
100 IBAVYR TB 600MG
100 BIPHENTIN CAPS 20MG
100 BIPHENTIN CAPS 30MG
100 BIPHENTIN CAPS 40MG
100 BIPHENTIN CAPS 50MG
50 BIPHENTIN CAPS 60MG
50 BIPHENTIN CAPS 80MG
50 BIPHENTIN CAPS 10MG
100 INSUL LANTUS CART
5X3.0ML INSUL LANTUS SOLOSTAR
5X3ML ALLEGRA 24 HOURS 120MG TB 18 ALLEGRA TB 60MG
36 VYVANSE CAPS 10MG
100 VYVANSE CAPS 20MG
100 VYVANSE CAPS 30MG
100 VYVANSE CAPS 40MG
100 VYVANSE CAPS 50MG
100 VYVANSE CAPS 60MG
100 MEZAVANT TB ER 1.2G
120 FLAMAZINE CR TUBE
50G LATUDA FCT 120MG
30 LATUDA FCT 20MG
30 LATUDA FCT 40MG
30 LATUDA FCT 60MG
30 LATUDA FCT 80MG
30 DEXILANT CP DR 30MG
90 DEXILANT CP DR 60MG
90 COPAXONE SYR PREFIL20MG/ML30 COPAXONE SYR PREFIL40MG/ML12 ZYBAN TB 150MG 100 TRIUMEQ TB 600/50/300MG UD30 TIVICAY TB 50MG
30
Delivery Date: 13/05/2019
You are hereby notified that the government intends to negotiate with one firm only as identified above. Should you have any questions concerning this requirement, contact the contracting officer identified above.
An Advance Contract Award Notice (ACAN) allows departments and agencies to post a notice, for no less than fifteen (15) calendar days, indicating to the supplier community that it intends to award a good, service or construction contract to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the requirements set out in the ACAN, the contracting authority may then proceed with the award.
However, should a Statement of Capabilities be found to meet the requirements set out in the ACAN, then the contracting authority will proceed to a full tendering process.
Suppliers who consider themselves fully qualified and available to provide the services/goods described herein, may submit a statement of capabilities in writing to the contact person identified in this Notice on or before the closing date of this Notice. The statement of capabilities must clearly demonstrate how the supplier meets the advertised requirements.
The PWGSC file number, the contracting officer's name and the closing date of the ACAN must appear on the outside of the envelope in block letters or, in the case of a facsimile transmission, on the covering page.
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
